Developer docs
API playgroundTry for free, no card

Search company profiles

Alliance to Zero

Full company profile

uuid002734r

Namestring
Alliance to Zero
Legal namestring
Alliance to Zero
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Alliance to Zero is a non-profit membership association founded on June 2, 2021, and headquartered in Burgdorf, Canton of Bern, Switzerland, operating under Articles 60 et seq. of the Swiss Civil Code. The organization serves as a pre-competitive consortium for pharmaceutical and biotech supply chain companies, currently comprising nine member companies: SCHOTT Pharma, Ypsomed, Datwyler, Sharp, Schreiner MediPharm, Körber Pharma, Harro Höfliger, HealthBeacon, and Resourcify. Its stated mission is to facilitate the transition of the pharmaceutical sector to compliance with net zero emissions in line with the Paris Climate Agreement.

The Alliance produces collaborative intellectual outputs and co-developed product solutions rather than commercial products. Its core deliverables include the PCF Guideline (a methodological framework for Product Carbon Footprint assessment of automated disposable injection devices), the 11 Ecodesign Principles for Injection Devices, Ecodesign for Machinery Principles, a Sustainable Plastics Whitepaper examining alternatives to fossil-based plastics, the Net Zero Requires Circularity publication, and the Secure Blister-Free Syringe (SBFS) Solution — a co-developed packaging innovation achieving 80% less plastic and 25% smaller dimensions. The organization actively engages with regulatory bodies, including submitting a consultation statement to the EU Circular Economy Act proposing a new 'Circular Material Use' category in the Waste Hierarchy.

The business model is membership-based: the Alliance is funded by contributions from its member companies rather than commercial product sales or service fees. Its go-to-market centers on industry thought leadership through conference participation (CPHI, Pharmapack, PDA conferences), workshop delivery (notably through a strategic partnership with Informa Markets/CPHI), and free publication of research papers and guidelines. Pricing is not publicly disclosed as the organization does not sell products directly to end customers.

Short descriptiontext

Alliance to Zero is a Swiss non-profit membership association founded in 2021 that brings together nine pharmaceutical supply chain companies to collaboratively develop methodologies, guidelines, and product solutions for decarbonizing the pharma sector and achieving net zero emissions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBurgdorf, Switzerland
HQ citystring
Burgdorf
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharma supply chain decarbonization, carbon footprint assessment, circular economy pharma, ecodesign injection devices, sustainable pharma packaging
Industry6 codes
PRIMARYEUABAKAC
Decarbonization Strategy & Marginal Abatement Cost Curve (MACC) Advisory
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Corporate Net-Zero & Climate Strategy Services (Targets, Transition Plans, SBTi Support)
SECONDARYEUABAKAD
Scope 1–3 GHG Inventory Strategy, Data Governance & Controls (advisory)
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Corporate Net-Zero & Climate Strategy Services (Targets, Transition Plans, SBTi Support)
SECONDARYEUABAKAA
Net-Zero Target Setting & SBTi/Net-Zero Standard Support
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Corporate Net-Zero & Climate Strategy Services (Targets, Transition Plans, SBTi Support)
SECONDARYEUABAKAH
Regulatory & Disclosure Strategy (CSRD/ESRS, ISSB/IFRS S2, SEC, TCFD)
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Corporate Net-Zero & Climate Strategy Services (Targets, Transition Plans, SBTi Support)
SECONDARYEUAHAJAL
Circular Economy & Waste/Materials Reporting (Zero waste, packaging)
Energy, Utilities & Environment/Environmental Compliance, Monitoring & Consulting/Sustainability, ESG & Corporate Environmental Reporting
SECONDARYEUABAKAJ
Net-Zero Assurance & Readiness Assessments (limited assurance prep, audit support)
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Corporate Net-Zero & Climate Strategy Services (Targets, Transition Plans, SBTi Support)
NAICS code2 codes
  • Business Associations813910
  • Environmental Consulting Services54162
SIC code1 code
  • Services-Membership Organizations8600
Product category
Pharmaceutical Supply Chain Sustainability Association
Social media profiles2 records
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Alliance to Zero is a non-profit membership association that brings together pharmaceutical and biotech supply chain companies to collaboratively develop methodologies, guidelines, and solutions for decarbonizing the sector. Its deliverables include the PCF Guideline for carbon footprint assessment of injection devices, ecodesign principles for injectors and machinery, circular economy frameworks, whitepapers on sustainable plastics, and co-developed innovations such as the Secure Blister-Free Syringe (SBFS) packaging solution.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Alliance to Zero is a non-profit membership association for pharma and biotech supply chain companies, not a traditional product company. The organization produces collaborative sustainability resources including the PCF Guideline (methodological framework for product carbon footprint assessment), Ecodesign Principles Paper (11 principles for sustainable injector device design), Ecodesign for Machinery Principles (machinery-related emissions reduction), Sustainable Plastics Whitepaper (alternatives to fossil-based plastics), Secure Blister-Free Syringe Solution (innovative packaging eliminating blister plastic), and Net Zero Requires Circularity paper. These publications and solutions are developed collectively by member companies to facilitate the pharmaceutical sector's transition to net zero emissions.

Product and service6 records
1PCF Guideline (Product Carbon Footprint methodology for injection devices)
2Ecodesign Principles Paper (11 principles for injection devices)
3Ecodesign for Machinery Principles
4Sustainable Plastics Whitepaper
5Secure Blister-Free Syringe (SBFS) Solution
6Net Zero Requires Circularity publication
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-10-28
Description

Strategic partnership with Informa Markets, organizer of CPhI (the world's largest pharmaceutical event platform), for joint workshops, panel discussions, and sustainability track programming. The collaboration includes workshops such as 'Speak the Same Language: Jumpstart Your Understanding of a Sustainable Supply Chain' and joint participation in the Sustainable Futures track at CPhI events.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with PDA to host workshops on 'The Circular Economy in Pharma', including a workshop on October 16th prior to the 2023 PDA Universe of Pre-filled Syringes and Injection Devices Conference in Gothenburg, Sweden.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Circular operating systems company that enables sustainable growth by digitising waste management, data-driven optimisation, and closed loop recycling programs. Joined as the 9th member of Alliance to Zero in June 2025 to contribute expertise in waste management and recycling to accelerate circular concepts for injection devices.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leader in pharmaceutical packaging, clinical trial supply services & small-scale sterile manufacturing with heritage spanning more than 70 years. Specializes in secondary packaging of injectables. Founding member of Alliance to Zero.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology supplier for realizing entire product ideas from laboratory stage to production, specializing in filling, assembly and packaging lines. Founding member representing machine/supplier perspective.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading developer and manufacturer of innovative, multifunctional specialty labels and marking solutions with value-added benefits for the healthcare industry. Founding member with expertise in functional labels for injection devices including first-opening indication and RFID.

7Körber Pharma
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Offers innovative, high-quality and sustainable pharma packaging solutions with customized Rondo and Dividella Solutions for monomaterial packaging. Founding member providing secondary packaging expertise.

alliancetozero.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global leading manufacturer in primary packaging for pharmaceuticals, producing annually more than 11 billion vials, ampoules, cartridges and syringes. Represented in 34 countries. Founding member providing primary packaging expertise and home of the current President (Dr. Arne Kloke).

9Datwyler
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Focuses on high-quality, system-critical elastomer components with leading positions in healthcare, mobility, and food & beverage. Headquartered in Switzerland with more than 20 operating companies and sales in over 100 countries. Founding member providing elastomer component expertise.

alliancetozero.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading developer and manufacturer of injection and infusion systems for self-medication and diabetes specialist with over 35 years' experience. Provides pens, auto injectors and infusion systems. Founding member providing drug delivery device expertise.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare technology company providing smart injection device management. Home of Marion Briggs, former Vice President of Alliance to Zero. Specializes in sustainability and Green Labs facility processing injection waste in a more circular manner.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeOthers
Description

A global disclosure system for environmental impacts, including pharma supply chain reporting. Comparable as the data and disclosure infrastructure that the Alliance's PCF methodologies feed into for Scope 1–3 reporting and supply chain transparency.

TypeDirect peer
Description

A non-profit, member-driven consortium of pharmaceutical and healthcare companies that promotes responsible supply chain practices, including environmental sustainability. Directly comparable as a pre-competitive pharma supply chain collaboration model that produces shared principles and audit frameworks.

3Manufacture 2030
TypeEmerging player
Description

A supply-chain sustainability platform helping manufacturers and their suppliers measure, report, and reduce carbon emissions and other environmental impacts. Comparable as it provides Scope 1–3 emissions data and decarbonization programs applicable to pharmaceutical supply chain participants.

TypeOthers
Description

A circular economy software platform for digitized waste management and closed-loop recycling programs. Comparable because it is the Alliance's newest member and a representative of the digital circularity tooling category that supports pharma device take-back and recycling.

TypeOthers
Description

A partnership organization defining and promoting best practice in science-based target setting for emissions reductions. Comparable because Alliance to Zero members (e.g., Körber) adopt SBTi-aligned roadmaps and the Alliance's PCF guidance supports SBTi target fulfillment across pharma.

TypeBroad incumbent
Description

The European pharma industry association representing R&D-based companies, with active sustainability and supply chain programs. Comparable as the EU-level industry body that competes with the Alliance for influence on EU circularity and decarbonization policy.

7AMR Industry Alliance
TypeDirect peer
Description

A coalition of biotech, diagnostics, generics, and research-based pharmaceutical companies that addresses antimicrobial resistance and broader sustainability across the value chain. Comparable as a pharma industry consortium producing shared sustainability guidance and engaging in regulatory advocacy.

8International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
TypeBroad incumbent
Description

The global trade association representing the research-based pharmaceutical industry, with sustainability and climate initiatives for the broader pharma sector. Comparable as the highest-level industry body whose agendas shape the operating context for Alliance to Zero's specialty work.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alliance to Zero

Pharmaceutical Supply Chain Sustainability Associationalliancetozero.com

Alliance to Zero is a Swiss non-profit membership association founded in 2021 that brings together nine pharmaceutical supply chain companies to collaboratively develop methodologies, guidelines, and product solutions for decarbonizing the pharma sector and achieving net zero emissions.

What Alliance to Zero does

Alliance to Zero is a non-profit membership association founded on June 2, 2021, and headquartered in Burgdorf, Canton of Bern, Switzerland, operating under Articles 60 et seq. of the Swiss Civil Code. The organization serves as a pre-competitive consortium for pharmaceutical and biotech supply chain companies, currently comprising nine member companies: SCHOTT Pharma, Ypsomed, Datwyler, Sharp, Schreiner MediPharm, Körber Pharma, Harro Höfliger, HealthBeacon, and Resourcify. Its stated mission is to facilitate the transition of the pharmaceutical sector to compliance with net zero emissions in line with the Paris Climate Agreement.

The Alliance produces collaborative intellectual outputs and co-developed product solutions rather than commercial products. Its core deliverables include the PCF Guideline (a methodological framework for Product Carbon Footprint assessment of automated disposable injection devices), the 11 Ecodesign Principles for Injection Devices, Ecodesign for Machinery Principles, a Sustainable Plastics Whitepaper examining alternatives to fossil-based plastics, the Net Zero Requires Circularity publication, and the Secure Blister-Free Syringe (SBFS) Solution — a co-developed packaging innovation achieving 80% less plastic and 25% smaller dimensions. The organization actively engages with regulatory bodies, including submitting a consultation statement to the EU Circular Economy Act proposing a new 'Circular Material Use' category in the Waste Hierarchy.

The business model is membership-based: the Alliance is funded by contributions from its member companies rather than commercial product sales or service fees. Its go-to-market centers on industry thought leadership through conference participation (CPHI, Pharmapack, PDA conferences), workshop delivery (notably through a strategic partnership with Informa Markets/CPHI), and free publication of research papers and guidelines. Pricing is not publicly disclosed as the organization does not sell products directly to end customers.

Alliance to Zero firmographics

Firmographics
Name
Alliance to Zero
Legal name
Alliance to Zero
Website
https://alliancetozero.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Alliance to Zero is a Swiss non-profit membership association founded in 2021 that brings together nine pharmaceutical supply chain companies to collaboratively develop methodologies, guidelines, and product solutions for decarbonizing the pharma sector and achieving net zero emissions.
Ownership category
akta.pro rank

Alliance to Zero industry classification

Industry
Product category
Pharmaceutical Supply Chain Sustainability Association
NAICS
Business Associations (813910), Environmental Consulting Services (54162)
SIC
Services-Membership Organizations (8600)
akta.pro industry
PRIMARYEUABAKAC
Decarbonization Strategy & Marginal Abatement Cost Curve (MACC) Advisory
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Corporate Net-Zero & Climate Strategy Services (Targets, Transition Plans, SBTi Support)
SECONDARYEUABAKAD
Scope 1–3 GHG Inventory Strategy, Data Governance & Controls (advisory)
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Corporate Net-Zero & Climate Strategy Services (Targets, Transition Plans, SBTi Support)
SECONDARYEUABAKAA
Net-Zero Target Setting & SBTi/Net-Zero Standard Support
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Corporate Net-Zero & Climate Strategy Services (Targets, Transition Plans, SBTi Support)
SECONDARYEUABAKAH
Regulatory & Disclosure Strategy (CSRD/ESRS, ISSB/IFRS S2, SEC, TCFD)
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Corporate Net-Zero & Climate Strategy Services (Targets, Transition Plans, SBTi Support)
SECONDARYEUAHAJAL
Circular Economy & Waste/Materials Reporting (Zero waste, packaging)
Energy, Utilities & Environment/Environmental Compliance, Monitoring & Consulting/Sustainability, ESG & Corporate Environmental Reporting
SECONDARYEUABAKAJ
Net-Zero Assurance & Readiness Assessments (limited assurance prep, audit support)
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Corporate Net-Zero & Climate Strategy Services (Targets, Transition Plans, SBTi Support)

Keywords

  • Pharma supply chain decarbonization
  • Carbon footprint assessment
  • Circular economy pharma
  • Ecodesign injection devices
  • Sustainable pharma packaging

Where Alliance to Zero is headquartered

Location

Headquarters

HQ city
Burgdorf
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Alliance to Zero business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Others

Distribution channels1 record

Marketing channels8 records

Alliance to Zero product offering

Product offering

Core offering

Alliance to Zero is a non-profit membership association that brings together pharmaceutical and biotech supply chain companies to collaboratively develop methodologies, guidelines, and solutions for decarbonizing the sector. Its deliverables include the PCF Guideline for carbon footprint assessment of injection devices, ecodesign principles for injectors and machinery, circular economy frameworks, whitepapers on sustainable plastics, and co-developed innovations such as the Secure Blister-Free Syringe (SBFS) packaging solution.

Product overview

Alliance to Zero is a non-profit membership association for pharma and biotech supply chain companies, not a traditional product company. The organization produces collaborative sustainability resources including the PCF Guideline (methodological framework for product carbon footprint assessment), Ecodesign Principles Paper (11 principles for sustainable injector device design), Ecodesign for Machinery Principles (machinery-related emissions reduction), Sustainable Plastics Whitepaper (alternatives to fossil-based plastics), Secure Blister-Free Syringe Solution (innovative packaging eliminating blister plastic), and Net Zero Requires Circularity paper. These publications and solutions are developed collectively by member companies to facilitate the pharmaceutical sector's transition to net zero emissions.

Differentiator

Problem solved

Functional benefit

Products and services

  • PCF Guideline (Product Carbon Footprint methodology for injection devices)
  • Ecodesign Principles Paper (11 principles for injection devices)
  • Ecodesign for Machinery Principles
  • Sustainable Plastics Whitepaper
  • Secure Blister-Free Syringe (SBFS) Solution
  • Net Zero Requires Circularity publication

Companies that use Alliance to Zero

Customer profile

Segments1 record

Ideal customer profiles1 record

Alliance to Zero technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Alliance to Zero partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • Informa Markets / CPHIcoreGTM or Marketing Partner · 28 October 2025Strategic partnership with Informa Markets, organizer of CPhI (the world's largest pharmaceutical event platform), for joint workshops, panel discussions, and sustainability track programming. The collaboration includes workshops such as 'Speak the Same Language: Jumpstart Your Understanding of a Sustainable Supply Chain' and joint participation in the Sustainable Futures track at CPhI events.
  • Parenteral Drug Association (PDA)coreStrategic or Co-development PartnerCollaboration with PDA to host workshops on 'The Circular Economy in Pharma', including a workshop on October 16th prior to the 2023 PDA Universe of Pre-filled Syringes and Injection Devices Conference in Gothenburg, Sweden.
  • ResourcifycoreStrategic or Co-development PartnerCircular operating systems company that enables sustainable growth by digitising waste management, data-driven optimisation, and closed loop recycling programs. Joined as the 9th member of Alliance to Zero in June 2025 to contribute expertise in waste management and recycling to accelerate circular concepts for injection devices.
  • SharpcoreStrategic or Co-development PartnerLeader in pharmaceutical packaging, clinical trial supply services & small-scale sterile manufacturing with heritage spanning more than 70 years. Specializes in secondary packaging of injectables. Founding member of Alliance to Zero.
  • Harro HöfligercoreStrategic or Co-development PartnerTechnology supplier for realizing entire product ideas from laboratory stage to production, specializing in filling, assembly and packaging lines. Founding member representing machine/supplier perspective.
  • Schreiner MediPharmcoreStrategic or Co-development PartnerLeading developer and manufacturer of innovative, multifunctional specialty labels and marking solutions with value-added benefits for the healthcare industry. Founding member with expertise in functional labels for injection devices including first-opening indication and RFID.
  • Körber PharmacoreStrategic or Co-development PartnerOffers innovative, high-quality and sustainable pharma packaging solutions with customized Rondo and Dividella Solutions for monomaterial packaging. Founding member providing secondary packaging expertise.
  • SCHOTT PharmacoreStrategic or Co-development PartnerGlobal leading manufacturer in primary packaging for pharmaceuticals, producing annually more than 11 billion vials, ampoules, cartridges and syringes. Represented in 34 countries. Founding member providing primary packaging expertise and home of the current President (Dr. Arne Kloke).
  • DatwylercoreStrategic or Co-development PartnerFocuses on high-quality, system-critical elastomer components with leading positions in healthcare, mobility, and food & beverage. Headquartered in Switzerland with more than 20 operating companies and sales in over 100 countries. Founding member providing elastomer component expertise.
  • YpsomedcoreStrategic or Co-development PartnerLeading developer and manufacturer of injection and infusion systems for self-medication and diabetes specialist with over 35 years' experience. Provides pens, auto injectors and infusion systems. Founding member providing drug delivery device expertise.
  • HealthBeaconminorStrategic or Co-development PartnerHealthcare technology company providing smart injection device management. Home of Marion Briggs, former Vice President of Alliance to Zero. Specializes in sustainability and Green Labs facility processing injection waste in a more circular manner.

Scale indicators3 records

Recent moves8 records

Expansion highlights4 records

Alliance to Zero competitors and assessment

Company assessment

Others

  • CDP (Carbon Disclosure Project): A global disclosure system for environmental impacts, including pharma supply chain reporting. Comparable as the data and disclosure infrastructure that the Alliance's PCF methodologies feed into for Scope 1–3 reporting and supply chain transparency.
  • Resourcify: A circular economy software platform for digitized waste management and closed-loop recycling programs. Comparable because it is the Alliance's newest member and a representative of the digital circularity tooling category that supports pharma device take-back and recycling.
  • Science Based Targets initiative (SBTi): A partnership organization defining and promoting best practice in science-based target setting for emissions reductions. Comparable because Alliance to Zero members (e.g., Körber) adopt SBTi-aligned roadmaps and the Alliance's PCF guidance supports SBTi target fulfillment across pharma.

Direct peers

  • Pharmaceutical Supply Chain Initiative (PSCI): A non-profit, member-driven consortium of pharmaceutical and healthcare companies that promotes responsible supply chain practices, including environmental sustainability. Directly comparable as a pre-competitive pharma supply chain collaboration model that produces shared principles and audit frameworks.
  • AMR Industry Alliance: A coalition of biotech, diagnostics, generics, and research-based pharmaceutical companies that addresses antimicrobial resistance and broader sustainability across the value chain. Comparable as a pharma industry consortium producing shared sustainability guidance and engaging in regulatory advocacy.

Emerging players

  • Manufacture 2030: A supply-chain sustainability platform helping manufacturers and their suppliers measure, report, and reduce carbon emissions and other environmental impacts. Comparable as it provides Scope 1–3 emissions data and decarbonization programs applicable to pharmaceutical supply chain participants.

Broad incumbents

  • European Federation of Pharmaceutical Industries and Associations (EFPIA): The European pharma industry association representing R&D-based companies, with active sustainability and supply chain programs. Comparable as the EU-level industry body that competes with the Alliance for influence on EU circularity and decarbonization policy.
  • International Federation of Pharmaceutical Manufacturers & Associations (IFPMA): The global trade association representing the research-based pharmaceutical industry, with sustainability and climate initiatives for the broader pharma sector. Comparable as the highest-level industry body whose agendas shape the operating context for Alliance to Zero's specialty work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Alliance to Zero social profiles

Digital presence

Alliance to Zero financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alliance to Zero leadership team

Management profile

Number of profiles

Profiles10 records

Alliance to Zero funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alliance to Zero M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alliance to Zero

What does Alliance to Zero do?

Alliance to Zero is a non-profit membership association that brings together pharmaceutical and biotech supply chain companies to collaboratively develop methodologies, guidelines, and solutions for decarbonizing the sector. Its deliverables include the PCF Guideline for carbon footprint assessment of injection devices, ecodesign principles for injectors and machinery, circular economy frameworks, whitepapers on sustainable plastics, and co-developed innovations such as the Secure Blister-Free Syringe (SBFS) packaging solution.

Is Alliance to Zero a public or private company?

Alliance to Zero is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Alliance to Zero founded?

Alliance to Zero was founded in 2021. It employs 1 to 10 people.

Where is Alliance to Zero based?

Alliance to Zero is headquartered in Burgdorf, Switzerland, in the Europe region.

Who are Alliance to Zero's main competitors?

Others on record are CDP (Carbon Disclosure Project), Resourcify and Science Based Targets initiative (SBTi). Direct peers are Pharmaceutical Supply Chain Initiative (PSCI) and AMR Industry Alliance. Manufacture 2030 is listed as an emerging player. Broad incumbents are European Federation of Pharmaceutical Industries and Associations (EFPIA) and International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).

Does Alliance to Zero have an API?

No public API is recorded for Alliance to Zero.

What industry is Alliance to Zero in?

Alliance to Zero's product category is Pharmaceutical Supply Chain Sustainability Association. Its primary akta.pro industry code is EUABAKAC, Decarbonization Strategy & Marginal Abatement Cost Curve (MACC) Advisory, with a secondary code of EUABAKAD, Scope 1–3 GHG Inventory Strategy, Data Governance & Controls (advisory). Its NAICS code is 813910 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales